Clinical Study to Evaluate Efficacy and Safety of ANT-301 in Patients With Knee Osteoarthritis in Grade III/IV by K/L

Summary

This is a phase I open study to evaluate the efficacy and safety of ANT-301 in patients with knee osteoarthritis K\&L Grade III/IV.

Timeline

Start

2024-10-22

Primary completion

2026-05-15

Completion

2026-05-15

Outcome

Met primary endpoint

release “ANT-301) 의 제 1 상 임상시험에 등록된 저용량군 환자의 12 주 추적관찰이 완료되었습니다 . 본 임상의 1 차 목표인 안전성 평가에서 이상반응없이 안전함이 확인되었습니다 .” anterogen.com ↗

Drugs

Indications